A Prospective Multicenter Randomized Controlled Trial for Comparing Drug-Coated and Conventional Balloon Angioplasty in Venous Anastomotic Stenosis of Hemodialysis Arteriovenous Grafts
- PMID: 38010504
- DOI: 10.1007/s00270-023-03536-5
A Prospective Multicenter Randomized Controlled Trial for Comparing Drug-Coated and Conventional Balloon Angioplasty in Venous Anastomotic Stenosis of Hemodialysis Arteriovenous Grafts
Abstract
Purpose: To evaluate the efficacy and safety of drug-coated balloon angioplasty compared to conventional balloon angioplasty in the treatment of dysfunctional arteriovenous grafts.
Materials and methods: This prospective, multicenter, randomized clinical trial enrolled 190 patients with venous anastomotic stenosis in arteriovenous grafts at five participating hospitals. During pre-dilation, 4 patients dropped out due to ruptures requiring further treatment (n = 2) and residual stenosis of > 30% (n = 2). On successful pre-dilation with a 7 mm conventional balloon, patients were randomized to undergo either a 7 mm drug-coated balloon (n = 94) or conventional balloon angioplasty (n = 92). The primary out-come measure was target lesion primary patency at 3 and 6 months. The secondary out-come measures included target lesion primary patency at 12 months and access circuit primary patency at 6 and 12 months, clinical and technical success rates, and 12-month mortality differences between the groups.
Results: The target lesion primary patency and access circuit patency rates at 3 and 6 months were significantly higher in drug-coated balloon angioplasty group as compared to conventional balloon angioplasty group. The technical and clinical success rates were 100% for both the groups. As a procedure-related complication, anastomotic site rupture occurred during pre-dilation in 4 cases. The number of deaths during the 12-month follow-up was one for each group. The number of early thrombotic events (at < 3 months) was significantly higher in the drug-coated balloon group (p = 0.002).
Conclusion: Drug-coated balloon angioplasty was more effective and safer for the treatment of dysfunctional arteriovenous grafts compared to conventional balloon angioplasty.
Keywords: Arteriovenous grafts; Conventional balloon angioplasty; Drug-coated balloon angioplasty; Randomized controlled trial; Venous anastomotic stenosis.
© 2023. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Similar articles
-
A randomized controlled trial of drug-coated balloon angioplasty in venous anastomotic stenosis of dialysis arteriovenous grafts.J Vasc Surg. 2020 Jun;71(6):1994-2003. doi: 10.1016/j.jvs.2019.07.090. Epub 2019 Oct 11. J Vasc Surg. 2020. PMID: 31611105 Clinical Trial.
-
Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts.J Vasc Surg. 2016 Nov;64(5):1400-1410.e1. doi: 10.1016/j.jvs.2016.04.035. Epub 2016 Jun 25. J Vasc Surg. 2016. PMID: 27353358 Clinical Trial.
-
Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas: A Multicenter Randomized Controlled Trial.Am J Kidney Dis. 2021 Jul;78(1):19-27.e1. doi: 10.1053/j.ajkd.2020.11.022. Epub 2021 Jan 5. Am J Kidney Dis. 2021. PMID: 33418016 Clinical Trial.
-
Editor's Choice - Paclitaxel Coated Balloon Angioplasty vs. Plain Balloon Angioplasty for Haemodialysis Arteriovenous Access Stenosis: A Systematic Review and a Time to Event Meta-Analysis of Randomised Controlled Trials.Eur J Vasc Endovasc Surg. 2021 Oct;62(4):597-609. doi: 10.1016/j.ejvs.2021.05.043. Epub 2021 Aug 20. Eur J Vasc Endovasc Surg. 2021. PMID: 34420890
-
A systematic review and meta-analysis of the risk of death and patency after application of paclitaxel-coated balloons in the hemodialysis access.J Vasc Surg. 2020 Dec;72(6):2186-2196.e3. doi: 10.1016/j.jvs.2020.04.525. Epub 2020 Jun 12. J Vasc Surg. 2020. PMID: 32540324
Cited by
-
Efficacy of drug-coated balloon versus uncoated balloon for dysfunctional dialysis access: a systematic review and meta-analysis.Clin Exp Nephrol. 2025 Jul;29(7):974-986. doi: 10.1007/s10157-025-02642-7. Epub 2025 Feb 24. Clin Exp Nephrol. 2025. PMID: 39992495
References
-
- Wu CC, Lin MC, Pu SY, Tsai KC, Wen SC. Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol. 2008;19:877–83. https://doi.org/10.1016/j.jvir.2008.02.016 . - DOI - PubMed
-
- Glanz S, Gordon DH, Butt KM, Hong J, Lipkowitz GS. The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas. Ann Surg. 1987;206:777–81. https://doi.org/10.1097/00000658-198712000-00015 . - DOI - PubMed - PMC
-
- Trerotola SO, Stavropoulos SW, Shlansky-Goldberg R, Tuite CM, Kobrin S, Rudnick MR. Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons. Radiology. 2004;231:259–62. https://doi.org/10.1148/radiol.2311030949 . - DOI - PubMed
-
- Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75:s1–164. https://doi.org/10.1053/j.ajkd.2021.02.002 . - DOI - PubMed
-
- Maleux G, Mijnsbrugge WV, Henroteaux D, Laenen A, Cornelissen S, Claes K, et al. Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae. J Vasc Interv Radiol. 2018;29:470–5. https://doi.org/10.1016/j.jvir.2017.10.023 . - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials